| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962765 | Vaccine | 2016 | 6 Pages |
Abstract
Pneumococcal 13-valent conjugate vaccine includes the serotypes which cause more respiratory complications in our series; these serotypes were not associated with higher mortality in our series. PCV-13 may have a potential role in preventing respiratory complications due to bacteraemic pneumonoccal pneumonia.
Keywords
PPV-23PCV-13PCV-7IPDPSIIQR95%CIFEV1/FVCPao2/Fio2Streptococcus pneumoniaestandard deviationBacteremiaintensive care unitICUCOPDChronic obstructive pulmonary diseaseInvasive pneumococcal diseasePneumonia severity index95% confidence intervalinterquartile rangeAcute respiratory failureodds ratioPneumococcal conjugate vaccinehuman immunodeficiency virusHIVC reactive proteinCRPCommunity-acquired pneumoniaCaP
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Francisco Sanz-Herrero, Concepción Gimeno-Cardona, Nuria Tormo-Palop, Estrella Fernández-Fabrellas, MarÃa Luisa Briones, Ángela Cervera-Juan, José Blanquer-Olivas,